当前位置：
X-MOL 学术
›
Expert Rev. Clin. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2023-12-25 , DOI: 10.1080/1744666x.2023.2294938 Diana Paredes-Ruiz 1 , Daniel Martín-Iglesias 1 , Guillermo Ruiz-Irastorza 1, 2
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2023-12-25 , DOI: 10.1080/1744666x.2023.2294938 Diana Paredes-Ruiz 1 , Daniel Martín-Iglesias 1 , Guillermo Ruiz-Irastorza 1, 2
Affiliation
Hydroxychloroquine (HCQ) and glucocorticoids (GCs) constitute the oldest and more used drugs in the treatment of systemic lupus erythematosus (SLE). Despite this long experience, both are still sub...
中文翻译：
平衡使用羟氯喹和糖皮质激素治疗系统性红斑狼疮的风险和益处
羟氯喹（HCQ）和糖皮质激素（GC）是治疗系统性红斑狼疮（SLE）最古老、最常用的药物。尽管有这么长的经验，两人仍然...
更新日期：2023-12-25
中文翻译：
平衡使用羟氯喹和糖皮质激素治疗系统性红斑狼疮的风险和益处
羟氯喹（HCQ）和糖皮质激素（GC）是治疗系统性红斑狼疮（SLE）最古老、最常用的药物。尽管有这么长的经验，两人仍然...
京公网安备 11010802027423号